Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3990_Библиотеки_им_академика_М_И_Перельмана
.pdf
201
тень НЦССХ им. А.Н. Бакулева РАМН. Сердечно-сосудистые заболева-
ния. – 2017. – Т. 18, № S6. – С. 193.
87. Эпикардиальный жир и фибрилляция предсердий: роль профиброгенных
медиаторов / Е.З. Голухова, О.И. Громова, Н.И. Булаева [и др.] // Кардиоло-
гия. – 2018. – Т. 58, № 7. – С. 59–65. – DOI: 10.18087/cardio.2018.7. 10145.
88. Эпикардиальный жир, ММР-9 и TIMP-1, как маркеры фиброза миокарда у
пациентов с фибрилляцией предсердий / О.И. Громова, Н.И. Булаева, А.З.
Жолбаева [и др.] // Бюллетень НЦССХ им. А.Н. Бакулева РАМН. Сердечно-
сосудистые заболевания. – 2017. – Т. 18, № S3. – С. 116.
89. ЭПОХА: Эпидимиология фибрилляции предсердий в репрезентативной вы-
борке Европейской части Российской федерации / Ю.В. Мареев, Д.С. Поля-
ков, Н.Г. Виноградова [и др.] // Кардиология. – 2022. – № 62 (4). – С. 12–19.
– DOI: 10.18087/cardio.2022.4.n1997.
90. Эффективность антикоагулянтной подготовки больных фибрилляцией
предсердий к восстановлению синусового ритма в реальной клинической
практике / В.В. Мазур, А.В. Ковсар, Е.А. Савинкова [и др.] // Вестник Ива-
новской медицинской академии – 2015. – № 20 (3). – С. 29–33.
91. A longitudinal study on left atrial thrombosis in patients with non-rheumatic atrial
fibrillation treated with anticoagulants / S. Scardi, C. Mazzone, C. Pandullo [et
al.] // G Ital Cardiol. – 1997. – Vol. 27, № 10. – P. 1036–1043.
92. Additional value of left atrial appendage geometry and hemodynamics when con-
sidering anticoagulation strategy in patients with atrial fibrillation with low
CHA2DS2-VASc scores / J.M. Lee, J.-B. Kim, J.-S. Uhm [et al.] // Heart
Rhythm. – 2017. – Vol. 14, № 1. – P. 297–1301. – DOI: 10.1016/j.hrthm.
2017.05.034
93. Advanced age, low left atrial appendage velocity, and Factor V promoter se-
quence variation as predictors of left atrial thrombosis in patients with nonvalvu-
lar atrial fibrillation / D.A. Zateyshchikov, A.N. Brovkin, D.A. Chistiakov, V.V.
Nosikov // Journal of Thrombosis and Thrombolysis. – 2010. – Vol. 30. – P. 192–
199. – https://doi.org/10.1007/s11239-010-0440-1.
https://t.me/med1917
202
94. AHA/ACC/HRS Focused update of the 2014 AHA/ACC/HRS guideline for the
management of patients with atrial fibrillation: a report of the American College
of cardiology/American Heart Association task force on clinical practice guide-
lines and the Heart Rhythm Society in collaboration with the Society of Thoracic
Surgeons / C.T. January, L.S. Wann, H. Calkins [et al.] // Circulation/ – 2019. –
Vol. 140. – P. 125–151. – DOI: 10.1161/CIR.0000000000000665.
95. Al-Saady, N.M. Left atrial appendage: structure, function, and role in thrombo-
embolism / N.M. Al-Saady, O.A. Obel, A.J. Camm // Heart. – 1999. – Vol. 82. –
P. 547–555. – http://dx.doi.org/10.1136/hrt.82.5.547.
96. Analysis of adverse events in the treatment of patients with non‐valvular atrial
fibrillation with oral anticoagulants: Data from the “ANTEY” Observational
study / S.Yu. Martsevich, Y.V. Lukina, N.P. Kutishenko [et al.] // Pharmaceuti-
cals. – 2022. – Vol. 15, № 10. – P. 1209. – DOI: 10.3390/ ph15101209. – EDN
BUXUMW.
97. Antithrombotic therapy for atrial fibrillation. CHEST guideline and expert panel
report / G.Y.H. Lip, A. Banerjee, G. Boriani [et al.] // CHEST. – 2018. – Vol.
154. № 5. – P. 1121–1201. – DOI: 10.1016/j.chest.2018.07.040
98. Antithrombotic therapy for patients with left ventricular mural thrombus / B. Lat-
tuca, N. Bouziri, M. Kerneis [et al.] // J Am Coll Cardiol. – 2020. – Vol. 75. – P.
1676–1685. – https://doi.org/10.1016/j.jacc.2020.01.057
99. Ashikhmin, Ya. Atrial contractile function and fibrosis in patients with paroxys-
mal atrial fibrillation in sinus rhythm / Ya. Ashikhmin, O.M. Drapkina //
Archivos de Cardiologia de Mexico. – 2022. – Vol. 92, № 4. – P. 431–437. –
DOI: 10.24875/ACM.21000135.
100. Assessment and management of the left atrial appendage thrombus in patients
with nonvalvular atrial fibrillation / Y. Zhan, J. Joza, M. Al Rawahi [et al.] // Ca-
nadian Journal of Cardiology. – 2018. – Vol. 34, № 3. – P. 252–261. – DOI:
10.1016/j.cjca.2017.12.008.
101. Assessment of left atrial mechanical function and synchrony in paroxysmal atrial
fibrillation with two-dimensional speckle tracking echocardiography / Z. Shang,
https://t.me/med1917
203
D. Su, T. Cong [et al.] // Echocardiography. – 2017. – Vol. 34. – P. 176–183.
[CrossRef]
102. Association between left atrial epicardial fat, left atrial volume, and the severity
of atrial fibrillation / A.R. van Rosendael, J.M. Smit, M. El’Mahdiui [et al.] // Eu-
ropace. – 2022. – Vol. 24. – P. 1223–1228. – https://doi.org/10.1093/ europa-
ce/euac031
103. Association between left atrial function assessed by speckle-tracking echocardi-
ography and the presence of left atrial appendage thrombus in patients with atrial
fibrillation / K. Kupczynska, B.W. Michalski, D. Miskowiec [et al.] // Anatol J
Cardiol. – 2017. – ⎯ Vol. 18. – P. 15–22. – DOI: 10.14744/AnatolJCardiol.
2017.7613
104. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation
/ C. Wong, M. Sun, A. Odutayo [et al.] // Circulation: Arrhythmia and Electro-
physiology. – 2016. – Vol. 9. – P. e004378. – DOI: 10.1161/CIRCEP.
116.004378.
105. Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients
with non-valvular atrial fibrillation / Wei Xia, Yan Wang, Tongqing Duan [et al.]
// Thromb Res. – 2015. – Vol. 136, № 6. – P. 1156–1159. – DOI: 10.1016/
j.thromres.2015.10.021.
106. Asymmetrical dimethylarginine level in atrial fibrillation / A. Cengel, A. Sa-
hinarslan, G. Biberoğlu [et al.] // Acta Cardiol. – 2008. – Vol. 63, № 1. – P. 33–
37. – DOI: 10.2143/ac.63.1.2025329.
107. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in
the subepicardium of human and sheep atria / P. Haemers, H. Hamdi, K. Guedj
[et al.] // Eur Heart J. – 2017. – Vol. 38. – P. 53–61. – DOI: 10.1093/eurheartj/
ehv625.
108. Atrial fibrillation type and renal dysfunction as important predictors of left atrial
thrombus / A. Kapłon-Cieślicka, M. Budnik, M. Gawałko [et al. // Heart. –
2019. – Vol. 105, № 17. – P. 1310–1315. – DOI: 10.1136/heartjnl-2018-314492.
https://t.me/med1917
204
109. Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria / N.
Suffee, T. Moore-Morris, P. Farahmand [et al.] // Proc Natl Acad Sci USA. –
2017. – Vol. 114. – P. 771–780. – DOI: 10.1073/pnas.1610968114.
110. Atrial thrombi – a prospective follow-up study over 3 years with transesophageal
echocardiography and cranial magnetic resonance imaging / P. Bernhardt, H.
Schmidt, C. Hammerstingl [et al.] // Echocardiography. – 2006. – Vol. 23. – P.
388–394. – DOI: 10.1111/j.1540-8175.2006.00225.x.
111. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial
fibrillation / G. Corrado, G. Tadeo, S. Beretta [et al.] // Chest. – 1999. – Vol. 115,
№ 1. – P. 140–143. – DOI: 10.1378/chest.115.1.140.
112. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with
nonvalvular atrial fibrillation / R. Doukky, H. Gage, V. Nagarajan [et al.] // Echo-
cardiography. – 2013. – Vol. 30, № 8. – P. 889–895. – DOI: 10.1111/
echo.12169.
113. Cardiovascular death in patients with atrial fibrillation is better predicted by left
atrial thrombus and spontaneous echocardiographic contrast as compared with
clinical parameters / B. Dawn, J. Varma, P. Singh et al. // J Am Soc Echocardi-
ogr. – 2005. – Vol. 18. – P. 199–205. – DOI: 10.1016/j.echo.2004.12.003.
114. Cardiovascular magnetic resonance of total and atrial pericardial adipose tissue: a
validation study and development of a 3-dimensional pericardial adipose tissue
model / R. Mahajan, P. Kuklik, S. Grover [et al.] // J Cardiovasc Magn Reson. –
2013. – Vol. 15. – P. 73. – DOI: 10.1186/1532-429X-15-73.
115. Cardioversion of nonrheumatic atrial fibrillation: reduced thromboembolisc com-
plications whith 4 weeks of precardioversion anticoagulation are to related to
atrial thrombus resolution / L.J. Collins, D.I. Silverman, P.S. Douglas, W.J. Man-
ning // Circulation. – 1995. – Vol. 92, № 2. – P. 160–163. – DOI:
10.1161/01.cir.92.2.160.
116. Clinical utility of left atrial asynchrony and mechanical function in patients with
hypertrophic cardiomyopathy / O. Candan, C. Gecmen, M. Kahyaolu [et al.] //
https://t.me/med1917
205
Acta Cardiol Sin. – 2022. – Vol. 38. – P. 141–150. – DOI: 10.6515/ACS.
202203_38(2).20210930A
117. Coagulopathy and antiphospholipid antibodies in patients with COVID-19 /
Y. Zhang, M. Xiao, S. Zhang [et al. // N Engl J Med. – 2020. – Vol. 382,
№ 17. – P. 38. – DOI: 10.1056 / NEJMc2007575.
118. Comparison of morphologic features and flow velocity of the left atrial append-
age among patients with atrial fibrillation alone, transient ischemic attack, and
cardioembolic stroke / Y. Lee, H.C. Park, Y. Lee, S.G. Kim // American Journal
of Cardiology. – 2017. – Vol. 119, № 10. – P. 1596–1604. – https://doi.org/
10.1016/j.amjcard.2017.02.016.
119. Correlation between left atrial appendage morphology and flow velocity in pa-
tients with paroxysmal atrial fibrillation / K. Fukushima, N. Fukushima, K. Kato
[et al.] // European Heart Journal – Cardiovascular Imaging. – 2016. – Vol. 17. –
P. 59–66. – https://doi.org/10.1093/ehjci/jev117
120. Cosansu, K. Is epicardial fat thickness associated with acute ischemic stroke in
patients with atrial fibrillation? / K. Cosansu, S. Yilmas // Journal of stroke and
cerebrovascular disease. – 2020. – Vol. 9. – P. 7. – DOI: 10.1016/
j.strokecerebrovasdis.2020.104900.
121. Delayed catastrophic thrombotic events in young and asymptomatic post
COVID‑19 patients / B.E. Fan, T. Umapathi, K. Chua [et al.] // J Thromb
Thrombolysis. – 2021. – Vol. 51, № 4. – P. 971–977. – DOI: 10.1007/ s11239-
020-02332-z.
122. Derivation and validation of E/e′ ratio as a parameter in the evaluation of left atrial
appendage thrombus formation in patients with nonvalvular atrial fibrillation / E.D.
Garcia-Sayan, M. Patel, M. Wassouf [et al.] // Int J Cardiovasc Imaging. – 2016. –
Vol. 32, № 9. – P. 1349–1356. – DOI: 10.1007/s10554-016-0916-y.
123. Diagnosis and management of left atrium appendage thrombosis in atrial fibrilla-
tion patients undergoing cardioversion / E. Melillo, G. Palmiero, A. Ferro [et al.]
// Medicina. – 2019. – Vol. 55. – P. 511. – DOI: 10.3390/medicina55090511
https://t.me/med1917
206
124. Diagnosis of cardiac thrombosis in patients with atrial fibrillation in the absence
of macroscopically visible thrombi / N. Masawa, Y. Yoshida, T. Joshita,
G. Ooneda // Virchows Arch A Pathol Anat Histopathol. – 1993. – Vol. 422. –
P. 67–71.
125. Direction-dependent conduction abnormalities in the chronically stretched atria /
C.X. Wong, B. John, A.G. Brooks [et al.] // Europace. – 2012. – Vol. 14. – P.
954–961. – DOI: 10.1093/europace/eur428.
126. Does the left atrial appendage morphology correlate with the risk of stroke in pa-
tients with atrial fibrillation? Results from a multicenter study / L.Di Biase,
P. Santangeli, M. Anselmino [et al.] // Journal of American College of Cardiolo-
gy. – 2012. – Vol. 60. – P. 531–538. – https://doi.org/10.1016/ j.jacc.2012.
04.032.
127. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular
relaxation and estimation of filling pressures / S.F. Naguen, K.J. Middleton, H.A.
Kopelen [et al.] // J Am Coll Cardiol. – 1997. – Vol. 30. – P. 1527–1533
128. EACVI/EHRA Expert Consensus Document on the role of multi-modality imag-
ing for the evaluation of patients with atrial fibrillation / E Donal., G.Y.H. Lip,
M. Galderisi [et al.] // Eur Heart J. – Cardiovasc Imaging. – 2016. – Vol. 17. –
P. 355–383. – DOI: 10.1093/ehjci/jev354.
129. Echocardiographic predictors of left atrial appendage thrombus formation / S.
Ayirala, S. Kumar, D.M. O’Sullivan, D.I. Silverman // J Am Soc Echocardiogr. –
2011. – Vol. 24, № 5. – P. 499–505. – DOI: 10.1016/ j.echo.2011.02.010.
130. Effect of metabolic syndrome on risk stratification for left atrial or left atrial ap-
pendage thrombus formation in patients with nonvalvular atrial fibrillation / Y.-Y.
Yu-Yang Chen, Q. Qi Liu, L. Liu [et al. // Chin Med J (Engl). – 2016. – Vol. 129,
№ 20. – P. 2395–2402. – DOI: 10.4103/0366–6999.191744.
131. Electroanatomical remodeling of the atria in obesity. Impact of adjacent epicardi-
al fat / R. Mahajan, A. Nelson, R.K. Pathak [et al.] // J Am Coll Cardiol EP. –
2018. – Vol. 4. – P. 1529–1540. – DOI: 10.1016/j.jacep.2018.08.014.
https://t.me/med1917
207
132. Electrophysiological, electroanatomical and structural remodeling of the atria as
consequence of sustained obesity / R. Mahajan, D.H. Lau, A.G. Brooks [et al.] // J
Am Coll Cardiol. – 2015. – Vol. 66. – P. 1–11. – DOI: 10.1016/j.jacc.2015.
04.058.
133. Elevated homocysteine increases the risk of left atrial/left atrial appendage
thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score /
Yan Yao, Mei-Sheng Shang, Li-Jian Gao [et al.] // Europace. – 2018. – Vol. 20,
№ 7. – P. 1093–1098. – DOI: 10.1093/europace/eux189.
134. Epicardial fat from echocardiography: a new method for visceral adipose tissue
prediction / G. Iacobellis, F. Assael, M.C. Ribaudo [et al.] // Obes Res. – 2003. –
Vol. 11. – P. 304–310. – DOI: 10.1038/oby.2003.45
135. ESC Guidelines for the diagnosis and management of atrial fibrillation developed
in collaboration with EACTS / G. Hindricks, T. Potpara, N. Dagres [et al. // Eur
Heart J. – 2020. – Vol. 00. – P. 1–125. – DOI: 10.1093/eurheartj/ehaa612
136. Excessive interatrial adiposity is associated with left atrial remodeling, augment-
ed contractile performance in asymptomatic population / Y.H. Lai, C.H. Yun,
C.H. Su [et al.] // Echo Research and Practice. – 2016. – Vol. 3. – P. 5–16. – DOI:
10.1530/ERP-15-0031.
137. Expression of the von Willebrand factor in atrial endocardium is increased in atri-
al fibrillation depending on the extent of structural remodeling / K. Kumagai, M.
Fukuchi, J. Ohta [et al. // Circ J. – 2004. – Vol. 68. – P. 321–327.
138. External validation of a novel transthoracic echocardiographic tool in predicting
left atrial appendage thrombus formation in patients with nonvalvular atrial fibril-
lation / R. Doukky, A. Khandelwal, E. Garcia-Sayan, H. Gage // Eur Heart J Car-
diovasc Imaging. – 2013. – Vol. 14, № 9. – P. 876–881. – DOI: 10.1093/
ehjci/jes313.
139. Fate of left atrial thrombi in patients with atrial fibrillation determined by
transesophageal echocardiography and cerebral magnetic resonance Imaging / P.
https://t.me/med1917
208
Bernhardt, H. Schmidt, C. Hammerstingl [et al. // Am J Cardiol. – 2004. – Vol. 94,
№ 6. – P. 801–804. – DOI: 10.1016/j.amjcard.2004.06.010.
140. Fatkin, D. Relations between left atrial appendage blood flow velocity, spontane-
ous echocardiographic contrast and thromboembolic risk in vivo / D. Fatkin, R.P.
Kelly, M.P. Feneley // J Am Coll Cardiol. ⎯1994. – Vol. 23, № 4. – P. 961–
969. – DOI: 10.1016/0735-1097(94)90644-0.
141. Findings of acute pulmonary embolism in COVID-19 patients / J. Chen,
X. Wang, S. Zhang [et al.] // Clinical and Applied Throm-
bosis/Hemostasis. ⎯2020. – Vol. 26. – P. 1–8. – DOI: 10.1177/
1076029620936772.
142. Frequency and significance of right atrial appendage thrombi in patients with per-
sistent atrial fibrillation or atrial flutter / A. Cresti, M.A. Garcia-Fernandez,
G. Miracapillo [et al.] // J Am Soc Echocardiogr. – 2014. – Vol. 27: –
P. 1200–1207.
143. Further and extended data are needed to assess the efficacy and safety profile of
NOACs for the treatment of LAA thrombosis. Clinical discussions in antithrom-
botic therapy management in patients with atrial fibrillation: a delphi consensus
panel, / N. Mumoli, C. Amellone, G. Antonelli [et al.]. // CJC Open. – 2020. –
Vol. 2. – P. 641–651. – https://doi.org/10.1016/j.cjco.2020.07.016.
144. GARFIELD-AF: A worldwide prospective registry of patients with atrial fibrilla-
tion at risk of stroke / J.P. Bassand, G. Kayani, K.S. Pieper [et al.] // Future Car-
diology. – 2021. – Vol. 17, № 1. – P. 19–38. – DOI: 10.2217/fca-2020-0014.
145. Global peak left atrial longitudinal strain assessed by transthoracic echocardiog-
raphy is a good predictor of left atrial appendage thrombus in patients in sinus
rhythm with heart failure and very low ejection fraction – an observational study /
J. Kurzawski, A. Janion-Sadowska, L. Zandecki [et al.] // Cardiovascular Ultra-
sound. – 2020. – Vol. 18. – P. 7. – https://doi.org/ 10.1186/s12947-020-00188-0
146. Heart Disease and Stroke Statistics – 2019 Update: A Report From the American
Heart Association / E.J. Benjamin, P. Muntner, A. Alonso [et al.] // Circulation. –
2019. – Vol. 139. – P. 56–528. – DOI: 10.1161/CIR. 0000000000000659.
https://t.me/med1917
209
147. Human epicardial adipose tissue induces fibrosis of the atrial myocardium
through the secretion of adipo-fibrokines / N. Venteclef, V. Guglielmi, E. Balse
[et al.] // Eur Heart J. – 2015. – Vol. 36, № 13. – P. 795–805. – DOI:
10.1093/eurheartj/eht099.
148. Iacobellis, G. Echocardiographic epicardial fat: a review of research and clinical
applications / G. Iacobellis, Н. Willens // J Am Soc Echocardiogr. – 2009. – Vol.
23. – P. 1311–1319. – DOI: 10.1016/j.echo.2009.10.013.
149. Impact of B-type natriuretic peptide level on the risk of left atrial appendage
thrombus in patients with nonvalvular atrial fibrillation: a prospective study / R.
Pant, M. Patel, E. Garcia-Sayan [et al.] // Cardiovasc Ultrasound. – 2015. – Vol.
14. – P. 4. – DOI: 10.1186/s12947-016-0047-6.
150. Impact of diastolic function parameters on the risk for left atrial appendage
thrombus in patients with nonvalvular atrial fibrillation: a prospective study / R.
Doukky, E. Garcia-Sayan, M. Patel [et al]. // J Am Soc Echocardiogr. – 2016. –
Vol. 29, № 6. – P. 545–553. – DOI: 10.1016/j.echo.2016.01.014.
151. Impact of increased orifice size and decreased flow velocity of left atrial append-
age on stroke in nonvalvular atrial fibrillation / J.M. Lee, J. Shim, J.S. Uhm [et
al.] // American Journal of Cardiology. – 2014. – Vol. 113. – P. 963–969. –
https://doi.org/10.1016/j.amjcard.2013.11.058.
152. Incidence and predictors of left atrial appendage thrombus in patients treated with
nonvitamin K oral anticoagulants versus warfarin before catheter ablation for
atrial fibrillation / J. Wyrembak, K.B. Campbell, B.A. Steinberg [et al.] // Am J
Cardiol. – 2017. – Vol. 119, № 7. – P. 1017–1022. – DOI:10.1016/
j.amjcard.2016.12.008
153. Incidence of thrombotic complications in critically ill ICU patients with COVID-
19 / F.A. Klok, M.J. Kruip, N.J. Van der Meer [et al.] // Thromb Res. – 2020. –
Vol. 191. – P. 145–147. – DOI: 10.1016/j.thromres. 2020.04.013.
154. Increased levels of red cell distribution width is correlated with presence of left
atrial stasis in patients with non-valvular atrial fibrillation / A. Kaya, C. Tukkan,
https://t.me/med1917
210
A.T. Alper [et al.] // North Clin Istanb. – 2017. – Vol. 4, № 1. – P. 66–72. – DOI:
10.14744/nci.2017.72324.
155. Inflammation of left atrial epicardial adipose tissue is associated with paroxysmal
atrial fibrillation / T. Kusayama, H. Furusho, H. Kashiwagi [et al.] // Journal of
Cardiology. – 2016. – Vol. 68. – P. 406–411. – DOI: 10.1016/ j.jjcc.2015.11.005
156. Interatrial septal thickness as a marker of structural and functional remodeling of
the left atrium in patients with atrial fibrillation / H.E. Lim, N.O. Na, S.I. Im [et
al.] // Korean J Intern Med. – 2015. – Vol. 30. – P. 808–820 – DOI:
10.3904/kjim.2015.30.6.808
157. Interatrial septal thickness is associated with the extent of left atrial complex
ffactionated atrial electrograms and acute procedural outcome in patients with
persistent atrial fibrillation / Y.M. Park, H.Ch. Park, J.-E. Ban [et al.] // Europace.
– 2015. – Vol. 17. – P. 1700–1707. – DOI: 10.1093/europace/euu40.3.
158. Intra-atrial dyssynchrony during sinus rhythm predicts recurrence after the first
catheter ablation of atrial fibrillation / L. Ciuffo, S. Tao, E.G. Ipek [et al.] // JACC
Cardiovasc Imaging. – 2019 February. – Vol. 12, № 2. – P. 310–319. – DOI:
10.1016/j.jcmg.2017.11.028.
159. Is epicardial fat depot associated with atrial fibrillation? A systematic review and
metaanalysis / M. Gaeta, F. Bandera, F. Tassinari [et al.] // Europace. – 2017. –
Vol. 19. – P. 747–752. – DOI: 10.1093/europace/euw398.
160. Klein, A.L. Role of transesophageal echocardiography-guided cardioversion of
patients with atrial fibrillation / A.L. Klein, R.D. Murray, R.A. Grimm // J Am
Coll Cardiol. – 2001. – Vol. 37. – P. 691–704. – DOI: 10.1016/s0735-
1097(00)01178-5.
161. Larina, V.N. Possible effects of coronavurus infection (COVID-19) on the cardi-
ovascular system / V.N. Larina, M.G. Golovko, V.G. Larin // Bulletin of Russian
State Medical University. – 2020. – № 2. – P. 5–12. – DOI:
10.24075/brsmu.2020.020.
162. Left atrial appendage. Embryology, anatomy, physiology, arrhythmia and thera-
peutic intervention / N. Naksuk, D. Padmanabhan, V. Yogeswaran, S.J. Asirvat-
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана